HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk
Frontotemporal Dementia Gene Therapy Trial Initiates Dosing

PBFT02, developed by Passage Bio, is delivered via intra cisterna magna administration to the brain.

CRISPR Therapeutic Ready to Dose in Duchenne Muscular Dystrophy

A single patient will be dosed with CRD-THM-001 in an upcoming trial.

NK Cell Therapy Trial Doses First Patient With Lymphoma

The FDA recently accepted the company’s BLA for omidubicel for priority review.

Around the Helix: Cell and Gene Therapy Company Updates – August 10, 2022

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Ide-Cel Shows Benefit in Earlier Use in R/R Multiple Myeloma

A recent comparison of health-related quality of life scores also favored ide-cel over belantamab mafodotin treatment.

IND Cleared for Non-Hodgkin Lymphoma T-Cell Therapy

Marker will initiate a company-sponsored study after an initial trial at Baylor College of Medicine showed positive safety data.